Effects of intrathecal MSC-derived neural progenitors (MSC-NP) treatment on biomarker levels in the CSF in patients with progressive multiple sclerosis
John Tuddenham, Violaine Harris, Saud Sadiq
Presented at the 68th annual meeting of the American Academy of Neurology, held April 15-21, 2016 in Vancouver, BC, Canada.